MedTrace Logo

Impact of an Increased Restrictive Factor of One Anastomosis Gastric Bypass on Metabolic Outcomes Type 2 Diabetes.

NCT06176443 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-11-21

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effect of an increased restrictive factor of one gastric anastomosis (OAGB) using a "FundoRing" fundoplication on metabolic outcomes in type 2 diabetes mellitus. The randomized controlled trial compared two interventional procedures: one group - using the original fundoplication procedure to enhance the restrictive effect and another group without fundoplication in the standard version of the OAGB.

Conditions

  • Obesity, Morbid
  • Diabetes Mellitus, Type 2

Interventions

PROCEDURE

One anastomosis gastric bypass with combined fundoplication

FundoRingOAGB

PROCEDURE

One anastomosis gastric bypass without combined fundoplication

OAGB

Sponsors & Collaborators

  • The Society of Bariatric and Metabolic Surgeons of Kazakhstan

    lead OTHER

Principal Investigators

  • Oral Ospanov, Professor · Society of Bariatric and Metabolic Surgeons of Kazakhstan" (SBMSK)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2024-01-13
Completion
2024-05-01

Countries

  • Kazakhstan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06176443 on ClinicalTrials.gov